© 2023 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2023 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
September 11, 2022
BNT211-01, a novel CAR-T cell therapy, was efficacious in treating patients with CLDN6-positive, relapsed/refractory solid cancers, according to a small clinical trial.
June 07, 2022
The use of the chemotherapy ifosfamide was associated with small improvements in survival outcomes in a group of patients with relapsed/refractory Ewing sarcoma, a rare type of bone or soft tissue cancer.
March 22, 2022
Zejula plus Avastin led to promising progression-free survival rates with no new side effects for patients with newly diagnosed, advanced ovarian cancer.
What I Wish I Knew Before Cancer
Gay and Bisexual Men With Prostate Cancer Have Unique Needs
How I Helped My Wife Die Peacefully
‘Jurassic Park’ Star Announced Lymphoma Diagnosis, Martina Navratilova Is Cancer-Free and More